Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$16.95 - $27.04 $243,605 - $388,618
14,372 New
14,372 $388,000
Q4 2022

Feb 02, 2023

BUY
$40.54 - $56.2 $195,727 - $271,333
4,828 New
4,828 $255,000
Q2 2022

Aug 01, 2022

SELL
$28.03 - $45.8 $180,485 - $294,906
-6,439 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$29.24 - $44.06 $31,052 - $46,791
-1,062 Reduced 14.16%
6,439 $266,000
Q4 2021

Feb 08, 2022

BUY
$39.32 - $61.61 $124,054 - $194,379
3,155 Added 72.6%
7,501 $320,000
Q3 2021

Nov 12, 2021

SELL
$44.0 - $65.8 $195,932 - $293,007
-4,453 Reduced 50.61%
4,346 $239,000
Q2 2021

Aug 13, 2021

BUY
$44.66 - $63.06 $67,123 - $94,779
1,503 Added 20.6%
8,799 $421,000
Q1 2021

May 14, 2021

BUY
$46.31 - $62.7 $57,794 - $78,249
1,248 Added 20.63%
7,296 $370,000
Q4 2020

Feb 09, 2021

BUY
$55.51 - $69.94 $152,708 - $192,404
2,751 Added 83.44%
6,048 $381,000
Q3 2020

Nov 13, 2020

BUY
$42.19 - $69.61 $139,100 - $229,504
3,297 New
3,297 $222,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.